bioRxivBioengineering
An ancestral vaccine induces anti-Omicron antibodies by hypermutation
S. Park, J. Choi, Y. Lee, J. Noh, N. Kim, J. Lee, G. Cho, S. Kim, D. K. Yoo, C. K. Kang, P. G. Choe, N. J. Kim, W. B. Park, S. Kim, M.-d. Oh, S. Kwon, J. Chung
Abstract
The immune escape of Omicron variants significantly subsides by the third dose of an mRNA vaccine. However, it is unclear how Omicron variant-neutralizing antibodies develop under repeated vaccination. We analyzed blood samples from 41 BNT162b2 vaccinees following the course of three injections and analyzed their B-cell receptor (BCR) repertoires at six time points in total. The concomitant reactivity to both ancestral and Omicron receptor-binding domain (RBD) was achieved by a limited number of BCR clonotypes depending on the accumulation of somatic hypermutation (SHM) after the third dose. Our findings suggest that SHM accumulation in the BCR space to broaden its specificity for unseen antigens is a counter protective mechanism against virus variant immune escape.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-CoV-2 mRNA vaccination
L. Paschold, B. Klee, … M. Binder·bioRxiv·Mar 1, 2022
- Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose
F. Muecksch, Z. Wang, … M. Nussenzweig·bioRxiv·Feb 14, 2022
- Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
L. Yang, M. Van Beek, … A. K. Chakraborty·bioRxiv·Aug 24, 2022
- A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron
- mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5
E. Andreano, I. Paciello, … R. Rappuoli·bioRxiv·Aug 4, 2022
- Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation